[
  {
    "ts": null,
    "headline": "Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.",
    "summary": "The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.",
    "url": "https://finnhub.io/api/news?id=1a01fcbc54ea2c680fa8078769b2a5a08b277779cba308bf10952f321054192c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761163295,
      "headline": "Tylenol-Maker Kenvue’s Stock Is Down 30% in 2025. Its Fate May Be in the FDA’s Hands.",
      "id": 137197768,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "The former consumer health unit of Johnson & Johnson remains mired in troubles surrounding Tylenol.",
      "url": "https://finnhub.io/api/news?id=1a01fcbc54ea2c680fa8078769b2a5a08b277779cba308bf10952f321054192c"
    }
  },
  {
    "ts": null,
    "headline": "This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?",
    "summary": "Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during pregnancy.",
    "url": "https://finnhub.io/api/news?id=2ae7981a1ecc5573f784e1896f2435e7a30cf862d78604e383d9cf43054319f4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761159227,
      "headline": "This Billionaire Investor Is ‘Thrilled’ to Own Kenvue Stock Despite Tylenol Turbulence. Should You Buy KVUE Here?",
      "id": 137217924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "Kenvue stock is down 28% in 2025 amid controversy surrounding its Tylenol brand, which is linked to autism when used during pregnancy.",
      "url": "https://finnhub.io/api/news?id=2ae7981a1ecc5573f784e1896f2435e7a30cf862d78604e383d9cf43054319f4"
    }
  },
  {
    "ts": null,
    "headline": "Kenvue Inc. (KVUE): A Bull Case Theory",
    "summary": "We came across a bullish thesis on Kenvue Inc. on X.com by ZeeContrarian1. In this article, we will summarize the bulls’ thesis on KVUE. Kenvue Inc.’s share was trading at $16.23 as of September 30th. KVUE’s trailing and forward P/E were 21.89 and 14.81 respectively according to Yahoo Finance. Donald Trump, despite having no medical background, has […]",
    "url": "https://finnhub.io/api/news?id=2ddf7eb4ad04d82fd13fc1f9602b1cebf9fed477bf8b4b5053779e6a8a789d0a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761098829,
      "headline": "Kenvue Inc. (KVUE): A Bull Case Theory",
      "id": 137188926,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on Kenvue Inc. on X.com by ZeeContrarian1. In this article, we will summarize the bulls’ thesis on KVUE. Kenvue Inc.’s share was trading at $16.23 as of September 30th. KVUE’s trailing and forward P/E were 21.89 and 14.81 respectively according to Yahoo Finance. Donald Trump, despite having no medical background, has […]",
      "url": "https://finnhub.io/api/news?id=2ddf7eb4ad04d82fd13fc1f9602b1cebf9fed477bf8b4b5053779e6a8a789d0a"
    }
  },
  {
    "ts": null,
    "headline": "Is There Now an Opportunity in Kenvue After Shares Fall 33% in 2025?",
    "summary": "If you’re eyeing Kenvue stock and asking yourself what to do next, you’re definitely not alone. There has been more than a little turbulence lately, and for anyone considering an entry or exit, understanding what’s really driving the recent moves is essential. Over just the past week, Kenvue’s price slipped another 7.6%, capping off a challenging month down 18.6%. The story only grows more dramatic when you zoom out to the full year, with shares off by nearly one-third since January. So,...",
    "url": "https://finnhub.io/api/news?id=b71809763911f874be20d89f30c77515d77648dc91ce2cc6106f6f6dc83ddca2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761091783,
      "headline": "Is There Now an Opportunity in Kenvue After Shares Fall 33% in 2025?",
      "id": 137188927,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "KVUE",
      "source": "Yahoo",
      "summary": "If you’re eyeing Kenvue stock and asking yourself what to do next, you’re definitely not alone. There has been more than a little turbulence lately, and for anyone considering an entry or exit, understanding what’s really driving the recent moves is essential. Over just the past week, Kenvue’s price slipped another 7.6%, capping off a challenging month down 18.6%. The story only grows more dramatic when you zoom out to the full year, with shares off by nearly one-third since January. So,...",
      "url": "https://finnhub.io/api/news?id=b71809763911f874be20d89f30c77515d77648dc91ce2cc6106f6f6dc83ddca2"
    }
  }
]